Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The objective of this study is to investigate the efficacy and safety of two different dose levels of NT 201 (75 U or 100 U per cycle), compared with placebo, in reducing the salivary flow rate, and the severity and frequency of chronic troublesome sialorrhea that occurs as a result of various neurological conditions in adult subjects.
Epistemonikos ID: 67e9c155c0a9c8d1c847c50c1b090ee34020ede4
First added on: May 11, 2024